ARCHIVES

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

Y-90 Radioembolization Stabilizes Liver Metastases in 98.5 Percent Of Breast Cancer Patients in Study

March 28, 2014

Old MSK Grant Reprogrammed, NIC Makes Final 1985 Construction Awards

July 5, 1985

AHRQ Draft Report Finds No Benefit For Biomarker Testing In Oncology

February 5, 2010

Beefed Up Centers Subcommittee Meets On Core Guidelines

December 2, 1977

Gallo’s Deputy Removed Pending Investigation

January 11, 1991

NCI Programs: Four Awarded Grants For Chem-Bio Centers; NCI To Commit $20M For Cancer Informatics Infrastructure

October 23, 1998